Accumulating evidence has demonstrated that suppression of GSK-3β activity results in overexpression of the HO-1 protein, subsequently ameliorating ischemic stroke-mediated neuronal injury [12,13]. The gene discussed is HMOX1; the disease is ischemic stroke.